ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 28

Differentiation, Activation, and Autoreactivity Of CD11c+ B Cells (ABCs)

Alice E. Wiedeman1, Natalia V. Giltiay2, Lena Tanaka3 and Keith B. Elkon3, 1Immunology, University of Washington, Seattle, WA, 2Department of Immunology, Division of Rheumatology, University of Washington, Seattle, WA, 3Rheumatology, University of Washington, Seattle, WA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Aging, autoantibodies, autoimmunity and toll-like receptors, B cells

  • Tweet
  • Email
  • Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recently, a population of CD11c+ age-associated B cells (ABCs) was identified in normal aged female mice. These cells could be expanded following activation by TLR7 agonists and their presence was associated with autoantibody production. The goals of the current study were to determine: a) when ABCs develop during B cell maturation in the spleen; b) how B cell intrinsic and extrinsic factors influence ABC generation; and c) how TLR7 expression influences ABC generation in a B cell receptor (BCR) transgenic (Tg) mouse with specificity for RNA (the TLR7 ligand).

Methods: Knock-in mice that overexpressed TLR7 on a B6 background (TLR7 Tg) were crossed with either IFNaR knockout (KO), RNAse Tg, HEL-specific BCR Tg, or RNA specific BCR Tg (H564) mice. Mixed chimeras were generated with combinations of wildtype B6 and TLR7 Tg bone marrow. Flow cytometry was used to identify splenic B cell subsets and analyze CD11c expression. CD11c+ (ABCs) and CD11c- (non-ABCs) B cells were sorted using a BD FACS Aria, and cultured for 6d with or without TLRs 4, 7, or 9 agonists. Ig production was quantified by ELISA.

Results: While in wildtype mice, CD11c+ ABCs were increased only in females greater than 6 months of age, TLR7 Tg mice had significantly expanded ABCs as young as 3 months in both males and females (1.1 ± 0.2 % in B6 versus 3.4 ± 1.1 % in TLR7 Tg, p < 0.003). ABC accumulation was greatest in the transitional B cell stages but the relative proportion of ABCs was also higher in marginal zone than follicular B cells. To address whether generation of ABCs was intrinsic or extrinsic we used WT:TLR7 Tg mixed bone marrow chimeras, and observed that ABC expansion of TLR7 Tg B cells had a definite cell-intrinsic component. However, when TLR7 Tg mice were crossed with RNAse Tg or IFNaR KO mice to remove the RNA ligand or response to IFN-I respectively, ABCs were modestly but statistically significantly reduced. In TLR7 Tg mice, serum levels of anti-RNA autoantibody correlated with % ABCs in spleen and we also observed that ABCs produced more antibody (including anti-RNA autoantibodies) in response to innate stimulation in vitro. Consistent with these findings, crossing TLR7 Tg and autoreactive H564 BCR mice further increased ABC accumulation, while crossing to an HEL mouse resulted in expansion of ABCs in the polyclonal but not in the HEL-specific subset.

Conclusion: CD11c+ ABCs are B cells that appear early during B cell maturation, and are increased under conditions of TLR7 hyperreactivity. ABC generation is, in part, cell intrinsic but is also influenced by exposure to self antigen and to IFN-I. ABCs can be directly implicated in autoantibody production by comparing antibody concentrations following stimulation of ABCs and non-ABCs in vitro as well as by enhanced ABC expansion in a TLR7 Tg mice that has specificity to self antigen (RNA) but not to non-self (HEL). Since these results suggested that ABCs, at least in part, contribute to autoantibody production, CD11c+ B cells may be a good target for amelioration of autoimmunity without broadly impairing host defense.


Disclosure:

A. E. Wiedeman,
None;

N. V. Giltiay,
None;

L. Tanaka,
None;

K. B. Elkon,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differentiation-activation-and-autoreactivity-of-cd11c-b-cells-abcs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology